Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Bristol-Myers Squibb Company

Bristol-Myers Squibb Company (BMY) Stock Overview

Explore Bristol-Myers Squibb Company’s financial performance, market position, analyst ratings, and future outlook.

BMY●NYSE
HealthcareDrug Manufacturers - General
$60.93
$0.77(1.28%)
U.S. Market opens in 14h 25m

Bristol-Myers Squibb Company (BMY)

Meyka AI Score

Z

Key Financials

Market Cap124.4B
P/E Ratio17.09
EPS (TTM)$5.93
ROE0.39%
Fundamental Analysis

AI Price Forecasts

1 Month$57.79
3 Months$64.76
1 Year Target$55.27

BMY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Bristol-Myers Squibb Company (BMY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 60.61, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $55.27.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 17.09 and a market capitalization of 124.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.28%
5-Day Change
3.64%
1-Month Change
11.39%
3-Month Change
2.59%
6-Month Change
11.80%
Year-to-Date (YTD) Change
12.96%
1-Year Change
30.50%
3-Year Change
-5.80%
5-Year Change
-9.28%
All-Time (Max) Change
2901.48%

Contact Information

https://www.bms.com
609 252 4621
Route 206 & Province Line Road, Princeton, NJ, 08543

Company Facts

325,000 Employees
IPO DateJun 1, 1972
CountryUS
Actively Trading

Frequently Asked Questions